Alembic Pharma gets USFDA nod for generic drug to treat breast cancer

Alembic Pharma gets USFDA nod for generic drug to treat breast cancer The approval granted by the US Food Drug Administration (USFDA) is for the abbreviated new drug application (ANDA), Fulvestrant injection of strength 250 mg/5 mL (50 mg/mL) per single-dose prefilled syringe, the company said in a statement.

from Moneycontrol Business News https://ift.tt/ZCYuT4g
Posted by: at
Tags:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

Start-up Street: Social justice and the start-up ecosystem

Disparities in start-ups are a global phenomenon and affirmative action is needed to ensure an equal opportunities environment for aspiring...